Market Place
Sourcing Support
PharmAla Issues Q2 Financial Statements and Grants Options
21 Apr 2026 //
GLOBENEWSWIRE
Cortexa Advances Commercialisation Of MDMA Supply In Australia
23 Mar 2026 //
GLOBENEWSWIRE
PharmAla Inks Supply & Data Deal For Phase 2 MDMA Trial
03 Mar 2026 //
GLOBENEWSWIRE
PharmAla Inks Drug Donation Deal For Fibromyalgia MDMA Therapy
26 Feb 2026 //
GLOBENEWSWIRE
PharmAla To Supply Amsterdam UMC with LaNeo MDMA
23 Feb 2026 //
GLOBENEWSWIRE
PharmAla Announces Changes To Board Of Directors
10 Feb 2026 //
GLOBENEWSWIRE
Pharmala Partners With Østfold Hospital Trust For Laneo MDMA
08 Jan 2026 //
GLOBENEWSWIRE
Pharmala Releases Audited 2025, Unaudited Q1 2026 Financials
24 Dec 2025 //
GLOBENEWSWIRE
PharmAla Biotech Contracts UK CDMO for ALA-002 Production
15 Dec 2025 //
GLOBENEWSWIRE
Pharmala Biotech Finishes Testing Laneo Capsules From Australia
10 Dec 2025 //
GLOBENEWSWIRE
PharmAla Files Final Base Shelf Prospectus and Signs Term Sheet
03 Nov 2025 //
GLOBENEWSWIRE
PharmAla Launches Nexus Portal for MDMA Prescribers & Therapists
08 Oct 2025 //
GLOBENEWSWIRE
PharmAla Completes Shipment Of Laneo™ MDMA To Johns Hopkins
02 Oct 2025 //
GLOBENEWSWIRE
PharmAla Files Revised Preliminary Base Shelf Prospectus
19 Sep 2025 //
GLOBENEWSWIRE
PharmAla Completes Import of LaNeo MDMA for US Distribution
08 Sep 2025 //
GLOBENEWSWIRE
PharmAla Incorporates Australian Entity for Clinical Research
03 Sep 2025 //
GLOBENEWSWIRE
PharmAla Delivers MDMA to Merhavim Mental Health Centre
07 Aug 2025 //
GLOBENEWSWIRE
PharmAla Issues Q3 Financial Statements
25 Jul 2025 //
GLOBENEWSWIRE
PharmAla Files Preliminary Base Shelf Prospectus
20 Jun 2025 //
GLOBENEWSWIRE
PharmAla Biotech Launches Phenesafe AI Drug Discovery Platform
15 May 2025 //
GLOBENEWSWIRE
PharmAla Issues Q2 Financial Statements
30 Apr 2025 //
GLOBENEWSWIRE
PharmAla Contracts with Partner to Act as US Distributor
24 Mar 2025 //
GLOBENEWSWIRE
PharmAla Ships LaNeo™ MDMA to University of Washington
21 Mar 2025 //
GLOBENEWSWIRE
PharmAla Signs Duchefa as Exclusive Distributor in Netherlands
10 Mar 2025 //
GLOBENEWSWIRE
PharmAla Completes Shipment of LaNeo MDMA for Schizophrenia Study
03 Mar 2025 //
GLOBENEWSWIRE
PharmAla To Supply STRONG STAR At UT Health With LaNeo MDMA
27 Feb 2025 //
GLOBENEWSWIRE
PharmAla Signs Advisory Agreement with Mr. Matthew Azrieli
06 Feb 2025 //
GLOBENEWSWIRE
PharmAla Issues Q1 Financial Statements
29 Jan 2025 //
GLOBENEWSWIRE
PharmAla Partners With MAPS Israel For Clinical Trial Data License
20 Jan 2025 //
GLOBENEWSWIRE
PharmAla Issues Audited Financials, Completes Ontario Continuance
20 Dec 2024 //
GLOBENEWSWIRE
PharmAla Reaches Agreement to Supply MDMA for Clinical Trial
14 Nov 2024 //
GLOBENEWSWIRE
PharmAla to supply LaNeo MDMA for Clinical Trial at Yale
07 Nov 2024 //
GLOBENEWSWIRE
PharmAla To Supply UT San Antonio With Novel LaNeo MDMA Form
08 Oct 2024 //
GLOBENEWSWIRE
PharmAla Supplies LaNeo MDMA to Harvard Maclean Hospital
02 Oct 2024 //
GLOBENEWSWIRE
PharmAla to supply Johns Hopkins Medicine for Clinical Trial
11 Sep 2024 //
GLOBENEWSWIRE
PharmAla Comments On FDA MDMA Decision, Announces ALA-002 Patent Grant
09 Aug 2024 //
GLOBENEWSWIRE
PharmAla Provides Investor Update After Q3 Financial Statement
30 Jul 2024 //
GLOBENEWSWIRE
PharmAla Biotech Signs Sale Agreement with Numinus
26 Mar 2024 //
GLOBENEWSWIRE
PharmAla-1 Molecule Receives US Patent Prosecution Highway Acceptance
08 Jan 2024 //
GLOBENEWSWIRE
PharmAla Biotech Receives Export Permit to Ship GMP LaNeo MDMA
16 Jun 2023 //
GLOBENEWSWIRE
PharmAla Biotech announces Non-Brokered Private Placement Offering
12 Jun 2023 //
GLOBENEWSWIRE
PharmAla Biotech to form Australian Psychedelics Joint Venture Vitura Health
01 May 2023 //
GLOBENEWSWIRE
PharmAla Biotech to supply Incannex with GMP LaNeo MDMA and Psilocybin
25 Apr 2023 //
GLOBENEWSWIRE
PharmAla Biotech to supply Clinical Psychedelic Lab at Monash University Trial
20 Apr 2023 //
GLOBENEWSWIRE
PharmAla Biotech and Filament Health Announce Release of GMP MDMA Capsules
11 Apr 2023 //
GLOBENEWSWIRE
PharmAla Biotech named Exclusive MDMA Supply Partner to Awakn Life Sciences
02 Mar 2023 //
GLOBENEWSWIRE
PharmAla Biotech Completes Annual General Meeting
01 Mar 2023 //
GLOBENEWSWIRE
Patent Application Published for PharmAla Biotech’s MDMA Analogs
23 Feb 2023 //
GLOBENEWSWIRE
PharmAla Biotech Closes Purchase Order With Emyria Ltd
14 Feb 2023 //
GLOBENEWSWIRE
